A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
Study sponsor: Spyre Therapeutics, Inc. · SYRE
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-10Estimated
Enrollment · participants150Estimated
Source updated2026-11-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.